| The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ... Journal of Thoracic Oncology 11 (1), 39-51, 2016 | 4243 | 2016 |
| Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer WK Kelly, OA O'Connor, LM Krug, JH Chiao, M Heaney, T Curley, ... Journal of clinical oncology 23 (17), 3923-3931, 2005 | 1089 | 2005 |
| Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non–small-cell lung cancer VA Miller, MG Kris, N Shah, J Patel, C Azzoli, J Gomez, LM Krug, W Pao, ... Journal of Clinical Oncology 22 (6), 1103-1109, 2004 | 953 | 2004 |
| Non–small cell lung cancer DS Ettinger, W Akerley, G Bepler, MG Blum, A Chang, RT Cheney, ... Journal of the national comprehensive cancer network 8 (7), 740-801, 2010 | 813 | 2010 |
| The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth … WD Travis, H Asamura, AA Bankier, MB Beasley, F Detterbeck, DB Flieder, ... Journal of Thoracic Oncology 11 (8), 1204-1223, 2016 | 639 | 2016 |
| Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma LM Krug, HI Pass, VW Rusch, HL Kindler, DJ Sugarbaker, ... Journal of Clinical Oncology 27 (18), 3007-3013, 2009 | 519 | 2009 |
| Non–small cell lung cancer, version 2.2013 DS Ettinger, W Akerley, H Borghaei, AC Chang, RT Cheney, LR Chirieac, ... Journal of the National Comprehensive Cancer Network 11 (6), 645-653, 2013 | 506 | 2013 |
| Non–small cell lung cancer DS Ettinger, W Akerley, H Borghaei, AC Chang, RT Cheney, LR Chirieac, ... Journal of the National Comprehensive Cancer Network 10 (10), 1236-1271, 2012 | 434 | 2012 |
| The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer K Chansky, FC Detterbeck, AG Nicholson, VW Rusch, E Vallières, ... Journal of Thoracic Oncology 12 (7), 1109-1121, 2017 | 422 | 2017 |
| Non–small cell lung cancer, version 6.2015 DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ... Journal of the National Comprehensive Cancer Network 13 (5), 515-524, 2015 | 405 | 2015 |
| The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the clinical and pathologic staging of small cell lung … AG Nicholson, K Chansky, J Crowley, R Beyruti, K Kubota, A Turrisi, ... Journal of Thoracic Oncology 11 (3), 300-311, 2016 | 401 | 2016 |
| Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR … AY Helena, CS Sima, J Huang, SB Solomon, A Rimner, P Paik, ... Journal of Thoracic Oncology 8 (3), 346-351, 2013 | 369 | 2013 |
| Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer MC Pietanza, SN Waqar, LM Krug, A Dowlati, CL Hann, A Chiappori, ... Journal of Clinical Oncology 36 (23), 2386-2394, 2018 | 360 | 2018 |
| Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical … F López-Ríos, S Chuai, R Flores, S Shimizu, T Ohno, K Wakahara, PB Illei, ... Cancer research 66 (6), 2970-2979, 2006 | 284 | 2006 |
| Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™ DS Ettinger, G Bepler, R Bueno, A Chang, JY Chang, LR Chirieac, ... JNCCN Journal of the National Comprehensive Cancer Network 4 (6), 548-582, 2006 | 273 | 2006 |
| Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center RM Flores, M Zakowski, E Venkatraman, L Krug, K Rosenzweig, J Dycoco, ... Journal of Thoracic Oncology 2 (10), 957-965, 2007 | 254 | 2007 |
| Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma HL Kindler, TG Karrison, DR Gandara, C Lu, LM Krug, JP Stevenson, ... Journal of clinical oncology 30 (20), 2509-2515, 2012 | 246 | 2012 |
| The IASLC lung cancer staging project: background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors … FC Detterbeck, WA Franklin, AG Nicholson, N Girard, DA Arenberg, ... Journal of Thoracic Oncology 11 (5), 651-665, 2016 | 243 | 2016 |
| The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming … FC Detterbeck, K Chansky, P Groome, V Bolejack, J Crowley, ... Journal of thoracic oncology 11 (9), 1433-1446, 2016 | 232 | 2016 |
| Non–small cell lung cancer, version 1.2015 DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ... Journal of the National Comprehensive Cancer Network 12 (12), 1738-1761, 2014 | 226 | 2014 |
